← All stocks

TENAX THERAPEUTICS, INC.

TENX Net buying
CIK 0000034956 #4570 in the set updated 17 Sep 2026
Bought (12 mo)
$5.02M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$5.02M
+$5.02M against sales at will

By person

6 insiders · 25 transactions
0.0×

Christopher T. Giordano holds only 0.0 times base salary in stock. $40.40K of shares against $563.73K in salary for 2025.

Salary from the company's own proxy. The shares are what Christopher T. Giordano last reported holding, valued at $1.82, the price Common Stock was last bought or sold at on the open market here, on 15 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
ADAR1 Capital Management, LLC entity
10% owner
$4.80M (7)
+$4.80M
11,377,969
$20.73M
+31.1%
Rich Stuart
Chief Medical Officer
$96.41K (5)
+$96.41K
10,266
$18.71K
+3,759%
MCGAULEY THOMAS
Interim CFO
$58.16K (3)
+$58.16K
7,000
$12.75K
Giordano Christopher Thomas
CEO
$40.09K (5)
+$40.09K
22,174
$40.40K
Almenoff June Sherie
Director
$14.94K (2)
+$14.94K
1,993
$3.63K
STAAB THOMAS R II
Chief Financial Officer
$10.98K (1)
+$10.98K
15,675
$28.56K

No percentages here. This company's share count has moved by a factor of 11.0 over the window, from 3,408,906 to 37,423,917 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Giordano Christopher Thomas
15 Sep 2026
CEO
Buy
4,850
$1.82
$8.84K
STAAB THOMAS R II
11 Sep 2026
Chief Financial Officer
Buy
5,675
$1.94
$10.98K
Giordano Christopher Thomas
11 Sep 2026
CEO
Buy
6,000
$1.88
$11.25K
ADAR1 Capital Management, LLC
3 Sep 2026
10% owner
Buy indirect
900,000
$1.78
$1.60M
ADAR1 Capital Management, LLC
2 Sep 2026
10% owner
Buy indirect
187,704
$1.80
$337.59K
ADAR1 Capital Management, LLC
1 Sep 2026
10% owner
Buy indirect
179,058
$1.80
$321.57K
ADAR1 Capital Management, LLC
31 Aug 2026
10% owner
Buy indirect
403,571
$1.79
$722.59K
ADAR1 Capital Management, LLC
24 Aug 2026
10% owner
Buy indirect
107,374
$1.75
$188.36K
ADAR1 Capital Management, LLC
21 Aug 2026
10% owner
Buy indirect
716,369
$1.77
$1.27M
ADAR1 Capital Management, LLC
20 Aug 2026
10% owner
Buy indirect
202,124
$1.78
$359.54K
Rich Stuart
9 Dec 2025
Chief Medical Officer
Buy
2,500
$10.22
$25.54K
Rich Stuart
8 Dec 2025
Chief Medical Officer
Buy indirect
2,500
$10.10
$25.25K
Rich Stuart
4 Dec 2025
Chief Medical Officer
Buy indirect
2,500
$9.20
$23.00K
Rich Stuart
3 Dec 2025
Chief Medical Officer
Buy
1,500
$9.08
$13.62K
Rich Stuart
2 Dec 2025
Chief Medical Officer
Buy
1,000
$9.01
$9.01K
Giordano Christopher Thomas
20 Nov 2025
CEO
Buy
538
$7.59
$4.08K
Giordano Christopher Thomas
19 Nov 2025
CEO
Buy
455
$7.51
$3.42K
Almenoff June Sherie
18 Nov 2025
Director
Buy
1,900
$7.52
$14.28K
Giordano Christopher Thomas
18 Nov 2025
CEO
Buy
1,612
$7.75
$12.50K
Almenoff June Sherie
17 Nov 2025
Director
Buy
93
$7.15
$664.95
MCGAULEY THOMAS
17 Nov 2025
Interim CFO
Buy indirect
5,000
$7.23
$36.14K
MCGAULEY THOMAS
17 Nov 2025
Interim CFO
Buy indirect
1,000
$7.35
$7.35K
MCGAULEY THOMAS
17 Nov 2025
Interim CFO
Buy
2,000
$7.34
$14.67K

What was left out

Form 4 filings counted 20
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 18,719
History held since 20 Oct 2016